EUVIMEDObjevte EUVIMED
Open access

TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer

Jun-Jie Ma, Cheng Xiang, Jian-Wei Wang

Aging · 2023-10-15 · 15 (19) · 10607-10626

DOI: 10.18632/aging.205100 ↗

At a glance

Journal article in Aging, published online on 2023-10-06. Written by Jun-Jie Ma and 2 co-authors. Institution: Department of Thyroid Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang, China. Major MEDLINE topics: MicroRNAs, Thyroid Neoplasms. Cited 5 times so far (Crossref); 46 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

OBJECTIVE: To investigate the role and clinical significance of threonine tyrosine kinase (TTK) in papillary thyroid cancer (PTC). METHODS: TTK expression in PTC and normal groups were compared using TCGA data and in vitro experiments. The prognostic value of TTK and its possible role in PTC dedifferentiation was evaluated. Next, TTK involvement in PTC occurrence and progression was analyzed via in vitro experiments. Subsequently, analyses of enrichment and immune cell infiltration were conducted to reveal the possible mechanism. Finally, we predicted the target miRNAs followed by performing a luciferase reporter experiment. RESULTS: TTK upregulation was observed in PTC, and its elevated level was significantly related to an unfavorable prognosis (P < 0.05). Interestingly, TTK negatively correlated with thyroid differentiation score (TDS), and patients with higher TDS showed longer survival (all P < 0.05). PTC cell growth, migration, and invasion were inhibited upon TTK knockdown. Besides, TTK was involved in metabolic processes and regulated cell adhesion molecules pathway. Its overexpression was positively associated with immune cell infiltrates (P < 0.05). Moreover, miR-582-5p was an upstream target of TTK. CONCLUSION: TTK serves as a potential biomarker for tumorigenesis and prognosis in PTC, especially for those that may differentiate into more aggressive thyroid cancers.

Subjects

MeSH terms (MEDLINE)

MicroRNAsThyroid NeoplasmsHumansThyroid Cancer, PapillaryProtein Serine-Threonine KinasesProtein-Tyrosine KinasesCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticCell Cycle Proteins

Author keywords

TTKbiomarkerpapillary thyroid cancerprognosistumorigenesis

Substances

Protein Serine-Threonine KinasesProtein-Tyrosine KinasesMicroRNAsTTK protein, humanCell Cycle ProteinsMIRN582 microRNA, human

Authors and institutions

  • Department of Thyroid Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang, China.
  • The Colorectal Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang, China.

Cite

APA

Ma, J. J., Xiang, C., & Wang, J. W. (2023). TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer. Aging, 15(19), 10607-10626. https://doi.org/10.18632/aging.205100

Vancouver

Ma JJ, Xiang C, Wang JW. TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer. Aging. 2023;15(19):10607-10626. doi:10.18632/aging.205100

BibTeX
@article{Ma2023,
  author = {Ma, Jun-Jie and Xiang, Cheng and Wang, Jian-Wei},
  title = {TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer},
  journal = {Aging},
  year = {2023},
  volume = {15},
  number = {19},
  pages = {10607--10626},
  doi = {10.18632/aging.205100}
}
Start for free →